Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ovulation is a physiological process in the female reproductive system where a mature egg (oocyte) is released from the dominant follicle of the ovary. This process is crucial for fertility and is regulated by hormonal changes, particularly follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estrogen. The LH surge triggers the rupture of the dominant follicle, leading to the release of the oocyte. After ovulation, the remnants of the follicle form the corpus luteum, which secretes progesterone to prepare the uterine lining for potential implantation. Anovulation, the absence of ovulation, can result from hormonal imbalances or other health conditions and leads to infertility. Ovulation can be induced by medications such as clomiphene, letrozole, and gonadotropins. Monitoring includes assessment of the LH surge and progesterone levels.
Ovulation induction via hormonal manipulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovulation.